blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3738602

EP3738602 - CYTOCIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.01.2024
Database last updated on 20.09.2024
FormerThe patent has been granted
Status updated on  10.02.2023
FormerGrant of patent is intended
Status updated on  12.10.2022
FormerRequest for examination was made
Status updated on  16.10.2020
FormerThe international publication has been made
Status updated on  19.07.2019
Most recent event   Tooltip30.08.2024Lapse of the patent in a contracting state
New state(s): MC		published on 02.10.2024 [2024/40]
Applicant(s)For all designated states
Fujita Academy
1-98 Dengakugakubo
Kutsukake-cho
Toyoake-shi, Aichi 470-1192 / JP
[2020/47]
Inventor(s)01 / SUGIHARA Kazuhiro
c/o Fujita Health University, FUJITA ACADEMY, 1-
98, Dengakugakubo, Kutsukake-cho
Toyoake-shi, Aichi 470-1192 / JP
02 / KANAYAMA Naohiro
c/o National University Corporation Hamamatsu
University School of Medicine, 20-1, Handayama 1-
chome, Higashi-ku
Hamamatsu-shi, Shizuoka 431-3192 / JP
03 / SHIBATA Toshiaki
c/o National University Corporation Hamamatsu
University School of Medicine, 20-1, Handayama 1-
chome, Higashi-ku
Hamamatsu-shi, Shizuoka 431-3192 / JP
04 / ONODERA Yuichiro
c/o National University Corporation Hamamatsu
University School of Medicine, 20-1, Handayama 1-
chome, Higashi-ku
Hamamatsu-shi, Shizuoka 431-3192 / JP
 [2020/47]
Representative(s)Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
[2020/47]
Application number, filing date18899050.128.12.2018
[2020/47]
WO2018JP48523
Priority number, dateJP2018000106309.01.2018         Original published format: JP 2018001063
[2020/47]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019138944
Date:18.07.2019
Language:JA
[2019/29]
Type: A1 Application with search report 
No.:EP3738602
Date:18.11.2020
Language:EN
[2020/47]
Type: B1 Patent specification 
No.:EP3738602
Date:15.03.2023
Language:EN
[2023/11]
Search report(s)International search report - published on:JP18.07.2019
(Supplementary) European search report - dispatched on:EP14.09.2021
ClassificationIPC:A61K38/10, A61K47/64, A61P35/00, A61P43/00, C07K7/08
[2020/47]
CPC:
C07K7/08 (EP,KR); A61K38/10 (EP,KR,US); A61P35/00 (EP,KR,US);
A61P43/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/47]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ZYTOZID[2020/47]
English:CYTOCIDE[2020/47]
French:CYTOCIDE[2020/47]
Entry into regional phase09.07.2020Translation filed 
09.07.2020National basic fee paid 
09.07.2020Search fee paid 
09.07.2020Designation fee(s) paid 
09.07.2020Examination fee paid 
Examination procedure08.11.2019Request for preliminary examination filed
International Preliminary Examining Authority: JP
09.07.2020Examination requested  [2020/47]
20.04.2022Amendment by applicant (claims and/or description)
13.10.2022Communication of intention to grant the patent
30.01.2023Fee for grant paid
30.01.2023Fee for publishing/printing paid
30.01.2023Receipt of the translation of the claim(s)
Opposition(s)18.12.2023No opposition filed within time limit [2024/08]
Fees paidRenewal fee
09.07.2020Renewal fee patent year 03
06.12.2021Renewal fee patent year 04
23.12.2022Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.03.2023
CZ15.03.2023
DK15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
IT15.03.2023
LT15.03.2023
LV15.03.2023
MC15.03.2023
NL15.03.2023
PL15.03.2023
RO15.03.2023
RS15.03.2023
SE15.03.2023
SI15.03.2023
SK15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
IS15.07.2023
PT17.07.2023
[2024/40]
Former [2024/26]AT15.03.2023
CZ15.03.2023
DK15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
IT15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
PL15.03.2023
RO15.03.2023
RS15.03.2023
SE15.03.2023
SI15.03.2023
SK15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
IS15.07.2023
PT17.07.2023
Former [2024/10]AT15.03.2023
CZ15.03.2023
DK15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
PL15.03.2023
RO15.03.2023
RS15.03.2023
SE15.03.2023
SI15.03.2023
SK15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
IS15.07.2023
PT17.07.2023
Former [2023/50]AT15.03.2023
CZ15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
PL15.03.2023
RO15.03.2023
RS15.03.2023
SE15.03.2023
SK15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
IS15.07.2023
PT17.07.2023
Former [2023/49]AT15.03.2023
CZ15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
RO15.03.2023
RS15.03.2023
SE15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
PT17.07.2023
Former [2023/48]AT15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
RS15.03.2023
SE15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
PT17.07.2023
Former [2023/46]ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
RS15.03.2023
SE15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
PT17.07.2023
Former [2023/38]FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
RS15.03.2023
SE15.03.2023
NO15.06.2023
GR16.06.2023
Former [2023/37]FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
RS15.03.2023
SE15.03.2023
NO15.06.2023
GR16.06.2023
Former [2023/36]FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
RS15.03.2023
SE15.03.2023
NO15.06.2023
Former [2023/35]HR15.03.2023
LT15.03.2023
RS15.03.2023
NO15.06.2023
Former [2023/34]LT15.03.2023
RS15.03.2023
Former [2023/33]LT15.03.2023
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[X]US2016145308  (FUKUDA MICHIKO [US], et al) [X] 1-5 * , claims, [0011]-[0012], [0051], [0140], [0215], [0262]-[0263], Figs. 4, 6, 8 & WO 2014/201118 A2 *;
 [A]  - SUGIHARA, K. et al., "Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis", Nat. Commun., (20140000), vol. 5, no. 4478, pages 1 - 9, XP055255332 [A] 1-5

DOI:   http://dx.doi.org/10.1038/ncomms5478
 [A]  - SUGIHARA, Kazuhiro, "Peptide drug discovery", Journal of Japan Society of Endometriosis, JP, (2015), vol. 36, pages 38 - 40, XP009521685 [A] 1-5
by applicantUS2016145308
 JP2018001063
    - SUGIHARA et al., NATURE COMMUNICATIONS, (20140000), vol. 5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.